Susquehanna Fundamental Investments, LLC Infla Rx N.V. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$3.62 - $6.34 $190,412 - $333,484	-52,600 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.82 - $5.32 $7,640 - $10,640	2,000 Added 3.95%	52,600 $265,000
Q3 2020 Nov 16, 2020	BUY	$3.7 - $5.47 $88,800 - $131,280	24,000 Added 90.23%	50,600 $216,000
Q2 2020 Aug 14, 2020	BUY	$4.59 - $8.96 $122,094 - $238,336	26,600 New	26,600 $122,000

13.8M

12.9K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $72.5M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.